Skip to content
Search

Latest Stories

NICE seeks feedback on annual BMI checks for adults with long-term conditions

Regular monitoring of BMI and waist-to-height ratio is a "powerful tool" to help prevent type 2 diabetes and heart disease.

NICE calls for annual BMI checks for adults with long-term conditions

Annual BMI measurements create early intervention opportunities for weight management

Getty Images

The National Institute for Health and Care Excellence (NICE) has published a draft quality standard recommending annual Body mass index (BMI) and waist-to-height measurements for adults with long-term conditions to help prevent weight-related complications.

A consultation has been launched to gather feedback from healthcare professionals and commissioners on the feasibility of implementing these proposals within the NHS.


The draft quality standard calls for yearly BMI measurements for all patients with long-term conditions and additional waist-to-height measurements for those with a BMI below 35.

NICE stated that these annual measurements will help identify individuals at risk of weight-related complications earlier, enabling them to receive timely support to prevent future health issues.

Professor Jonathan Benger, deputy chief executive and chief medical officer at NICE, explained: “These simple annual measurements create opportunities for early intervention and conversations about long-term health and wellbeing.”

“By identifying trends before they become problems, clinical practitioners can help people prevent more serious health complications down the line.”

He emphasised that tracking BMI and waist-to-height ratio annually is “a powerful tool” in preventing conditions such as type 2 diabetes, heart disease, and other obesity-related health issues.

Currently, while people with long-term conditions undergo routine physical health checks, BMI and waist-to-height measurements are not consistently recorded.

NICE’s new approach aims to address this inequality in care.

Its draft quality standard focuses on adults with conditions such as COPD, diabetes, heart failure, learning disabilities, rheumatoid arthritis, schizophrenia, and stroke, though this isn't a definitive list.

“We want to hear from healthcare professionals and commissioners during the consultation period to understand whether the proposals we've made can be implemented in the NHS,” said Dr Rebecca Payne, GP and chair of quality standards advisory committee at NICE.

NICE’s draft quality standard also stresses the importance of improving access to weight management services for people with learning disabilities, providing information on available interventions, and ensuring follow-up care for those prescribed weight management medicines or discharged from bariatric surgery services.

The consultation, which opened on 18 March, will run until 15 April 2025, with the final quality standard expected in August 2025.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less